Literature DB >> 17899019

Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys.

Matthew L Banks1, Jon E Sprague, Paul W Czoty, Michael A Nader.   

Abstract

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is frequently used in hot environments, such as rave parties. Studies in laboratory animals have shown that ambient temperature can alter the behavioral and neurochemical effects of MDMA.
OBJECTIVE: To examine the influence of ambient temperature on the relative reinforcing strength of MDMA and reinstatement of behavior previously maintained by MDMA is the objective of the study.
METHODS: The effects of cool (18 degrees C), room (24 degrees C), and warm (31 degrees C) temperatures were examined when MDMA was available under a concurrent fixed-ratio 30 schedule of MDMA (saline, 0.03-0.3 mg/kg/injection) and food choice in rhesus monkeys (n = 5). During saline substitutions, the effect of noncontingent MDMA (0.03-0.3 mg/kg) on response allocation was examined at each ambient temperature.
RESULTS: At room temperature, MDMA choice increased as a function of dose, such that food was preferred over a low MDMA dose (0.03 mg/kg/injection), whereas higher doses were preferred over food. Elevating the ambient temperature significantly increased the relative reinforcing strength of 0.03 mg/kg/injection MDMA, and lowering the ambient temperature significantly attenuated the choice of 0.1 mg/kg/injection MDMA. Noncontingent injections of MDMA administered before a session in which saline was the alternative to food dose-dependently increased injection-lever responding; this effect was not influenced by ambient temperature.
CONCLUSIONS: These results suggest that ambient temperature can affect the relative reinforcing strength of MDMA, but not MDMA-induced reinstatement. Furthermore, these results suggest environmental strategies for decreasing the reinforcing strength of MDMA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899019      PMCID: PMC2268611          DOI: 10.1007/s00213-007-0932-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Models of relative reinforcing efficacy of drugs and their predictive utility.

Authors:  J.L. Katz
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

2.  Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys.

Authors:  Carol A Paronis; Maciej Gasior; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2002-07-30       Impact factor: 4.530

Review 3.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

4.  Assessment of the relative reinforcing strength of cocaine in socially housed monkeys using a choice procedure.

Authors:  Paul W Czoty; Ciara McCabe; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2004-08-30       Impact factor: 4.030

5.  Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Renee Claytor; Jason T Ross; Beth A Reboussin; Amy Hauck Newman; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2007-02-01       Impact factor: 4.030

6.  Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.

Authors:  Kirsten C Morley; Jennifer L Cornish; Kong M Li; Iain S McGregor
Journal:  Pharmacol Biochem Behav       Date:  2004-10       Impact factor: 3.533

Review 7.  An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

Authors:  J E Sprague; S L Everman; D E Nichols
Journal:  Neurotoxicology       Date:  1998-06       Impact factor: 4.294

8.  Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.

Authors:  Maciej Gasior; Carol A Paronis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2003-10-16       Impact factor: 4.030

9.  D-Amphetamine reinstates behavior previously maintained by food: importance of context.

Authors:  A L Odum; T A Shahan
Journal:  Behav Pharmacol       Date:  2004-11       Impact factor: 2.293

10.  Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

Authors:  P M Beardsley; R L Balster; L S Harris
Journal:  Drug Alcohol Depend       Date:  1986-10       Impact factor: 4.492

View more
  13 in total

1.  The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.

Authors:  K S Murnane; H L Kimmel; K C Rice; L L Howell
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

Review 2.  Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning.

Authors:  Travis P Todd; Drina Vurbic; Mark E Bouton
Journal:  Neurobiol Learn Mem       Date:  2013-08-30       Impact factor: 2.877

3.  Development of translational preclinical models in substance abuse: Effects of cocaine administration on cocaine choice in humans and non-human primates.

Authors:  Richard W Foltin; Margaret Haney; Eric Rubin; Stephanie C Reed; Nehal Vadhan; Rebecca Balter; Suzette M Evans
Journal:  Pharmacol Biochem Behav       Date:  2015-04-28       Impact factor: 3.533

4.  Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.

Authors:  Blake A Hutsell; Kejun Cheng; Kenner C Rice; Sidney Stevens Negus; Matthew L Banks
Journal:  Addict Biol       Date:  2015-01-08       Impact factor: 4.280

5.  Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats.

Authors:  S Schenk; D Gittings; J Colussi-Mas
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

6.  Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys.

Authors:  K S Murnane; W E Fantegrossi; J R Godfrey; M L Banks; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2010-05-13       Impact factor: 4.030

7.  Relationship between response rates and measures of reinforcing strength using a choice procedure in monkeys.

Authors:  Matthew L Banks; Robert W Gould; Paul W Czoty; Michael A Nader
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

8.  Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.

Authors:  William E Fantegrossi; Rayna M Bauzo; Daniel M Manvich; Jose C Morales; John R Votaw; Mark M Goodman; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2009-05-07       Impact factor: 4.530

9.  Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys.

Authors:  Matthew L Banks; Paul W Czoty; Jon E Sprague; Michael A Nader
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

10.  High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration.

Authors:  Shawn M Aarde; Pai-Kai Huang; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2017-10-17       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.